| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner
2 companies
Schmertzler Michael is a 10% Owner at HLNE with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $63.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 1,500 | $27.81 | $41,715.00 | -1.3% | -10.4% | +48.7% | |
| Jun 7, 2023 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 1,000 | $44.86 | $44,860.00 | -0.8% | -10.7% | -15.3% | |
| Mar 16, 2020 | PTCT Ptc Therapeutics, Inc. | Director | Buy | 10,000 | $32.48 | $324,846.00 | +11.1% | - | - | |
| Jan 25, 2019 | PTCT Ptc Therapeutics, Inc. | Director | Buy | 66,225 | $30.20 | $1,999,995.00 | +5.0% | - | - |